» Articles » PMID: 34276211

In Silico Integrative Approach Revealed Key MicroRNAs and Associated Target Genes in Cardiorenal Syndrome

Overview
Publisher Sage Publications
Specialty Biology
Date 2021 Jul 19
PMID 34276211
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiorenal syndromes constellate primary dysfunction of either heart or kidney whereby one organ dysfunction leads to the dysfunction of another. The role of several microRNAs (miRNAs) has been implicated in number of diseases, including hypertension, heart failure, and kidney diseases. Wide range of miRNAs has been identified as ideal candidate biomarkers due to their stable expression. Current study was aimed to identify crucial miRNAs and their target genes associated with cardiorenal syndrome and to explore their interaction analysis. Three differentially expressed microRNAs (DEMs), namely, hsa-miR-4476, hsa-miR-345-3p, and hsa-miR-371a-5p, were obtained from GSE89699 and GSE87885 microRNA data sets, using R/GEO2R tools. Furthermore, literature mining resulted in the retrieval of 15 miRNAs from scientific research and review articles. The miRNAs-gene networks were constructed using miRNet (a Web platform of miRNA-centric network visual analytics). CytoHubba (Cytoscape plugin) was adopted to identify the modules and the top-ranked nodes in the network based on Degree centrality, Closeness centrality, Betweenness centrality, and Stress centrality. The overlapped miRNAs were further used in pathway enrichment analysis. We found that hsa-miR-21-5p was common in 8 pathways out of the top 10. Based on the degree, 5 miRNAs, namely, hsa-mir-122-5p, hsa-mir-222-3p, hsa-mir-21-5p, hsa-mir-146a-5p, and hsa-mir-29b-3p, are considered as key influencing nodes in a network. We suggest that the identified miRNAs and their target genes may have pathological relevance in cardiorenal syndrome (CRS) and may emerge as potential diagnostic biomarkers.

Citing Articles

Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies.

Zhao B, Hu X, Wang W, Zhou Y Acta Pharmacol Sin. 2025; .

PMID: 39910210 DOI: 10.1038/s41401-025-01476-z.


Molecular remodeling in comorbidities associated with heart failure: a current update.

Appunni S, Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, Khosla A Mol Biol Rep. 2024; 51(1):1092.

PMID: 39460797 PMC: 11512903. DOI: 10.1007/s11033-024-10024-7.


The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3.

Liu Y, Guan X, Shao Y, Zhou J, Huang Y Rev Cardiovasc Med. 2024; 24(2):52.

PMID: 39077418 PMC: 11273121. DOI: 10.31083/j.rcm2402052.


Progress and Challenges of Understanding Cardiorenal Syndrome Type 3.

Neres-Santos R, Armentano G, da Silva J, Falconi C, Carneiro-Ramos M Rev Cardiovasc Med. 2024; 24(1):8.

PMID: 39076878 PMC: 11270482. DOI: 10.31083/j.rcm2401008.


In silico medicine and -omics strategies in nephrology: contributions and relevance to the diagnosis and prevention of chronic kidney disease.

Checa-Ros A, Locascio A, Steib N, Okojie O, Malte-Weier T, Bermudez V Kidney Res Clin Pract. 2024; 44(1):49-57.

PMID: 39034863 PMC: 11838848. DOI: 10.23876/j.krcp.23.334.


References
1.
Vlachos I, Zagganas K, Paraskevopoulou M, Georgakilas G, Karagkouni D, Vergoulis T . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460-6. PMC: 4489228. DOI: 10.1093/nar/gkv403. View

2.
Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L . Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest. 2009; 119(9):2634-47. PMC: 2735940. DOI: 10.1172/JCI38864. View

3.
Wang G, Kwan B, Lai F, Chow K, Kam-Tao Li P, Szeto C . Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers. 2011; 30(4):171-9. PMC: 3825242. DOI: 10.3233/DMA-2011-0766. View

4.
Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View

5.
You G, Zu B, Wang B, Fu Q, Li F . Identification of miRNA-mRNA-TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot. Front Genet. 2020; 11:552. PMC: 7303929. DOI: 10.3389/fgene.2020.00552. View